Psyence Biomedical Ltd Common Shares
Quarterly Financials
| Values in thousands | 2025-09-30 | 2024-09-30 |
|---|---|---|
Revenue | $0 | $0 |
Gross Profit | -1 | |
EBITDA | -749 | |
EBIT | -750 | -1,157 |
Net Income | -753 | 141 |
Net Change In Cash | 0 | 0 |
Free Cash Flow | ||
Cash | 7,197 | 1,932 |
Basic Shares | 1,481 | 12 |
Annual Financials
| Values in thousands | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -4 | |||
EBITDA | -6,921 | 1,025 | -51,105 | 10,768 |
EBIT | -6,926 | 1,021 | -51,106 | -1,293 |
Net Income | -6,936 | 1,011 | -51,159 | 8,014 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -8,643 | -3,744 | -2,951 | -519 |
Cash | 7,444 | 6,135 | 762 | 15 |
Basic Shares | 2,293 | 568 | 6,517 | 32,674 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | -$0.51 |
2025-03-31 | -$99.97 |
2024-12-31 | $4.06 |
2024-09-30 | $25.45 |